MedTest Dx is manufacturing the only FDA approved quantitative test for G6PD, a critical factor when considering COVID-19 Treatment with chloroquine and hydroxychloroquine.

Allm is providing its COVID-19 Image Set for free to help improve diagnostic accuracy of COVID-19 cases.

Sygnature Group is supporting the UK Government’s COVID-19 testing strategy with the loan of a key piece of liquid handling equipment.

Horizon Discovery has announced special commercial licensing terms to facilitate rapid access to its cGMP-compliant CHOSOURCE™ platform for the development or production of therapeutic proteins, diagnostic assay components or vaccines relating to COVID-19.

Inspirata has been joined by Hamamatsu and KiKo in providing a free remote pathology initiative, available to healthcare institutions looking to provide flexibility to their staff during COVID-19

MagSi-NA Pathogens Kit from AMSBIO are designed to enable easy extraction of DNA and RNA from serum, plasma, oropharyngeal swab/nasopharyngeal swab, and any other respiratory samples for pathogen detection.

Avacta has entered into a collaboration with Cytiva to develop and manufacture a point-of-care rapid test intended for screening of large populations to diagnose the COVID-19 coronavirus infection.

In response to the global COVID-19 pandemic, Beckman Coulter has announced that it is developing assays to identify IgM and IgG antibodies to SARS-CoV-2.

Zegami has developed a new machine learning model using x-rays of COVID-19 infected lungs, artificial intelligence techniques and data visualization tools that could help medical professionals identify coronavirus cases more effectively.

The Promega amplification reagent has been added to the EUA list for laboratories that follow CDC’s testing protocols.